Compare ASMB & CLDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASMB | CLDT |
|---|---|---|
| Founded | 2005 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 440.0M | 362.9M |
| IPO Year | 2010 | N/A |
| Metric | ASMB | CLDT |
|---|---|---|
| Price | $29.44 | $8.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $44.20 | $9.50 |
| AVG Volume (30 Days) | 70.0K | ★ 202.8K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 4.18% |
| EPS Growth | ★ 91.78 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $1.29 |
| Revenue Next Year | $235.63 | N/A |
| P/E Ratio | ★ N/A | $610.21 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.68 | $6.08 |
| 52 Week High | $39.71 | $8.71 |
| Indicator | ASMB | CLDT |
|---|---|---|
| Relative Strength Index (RSI) | 53.25 | 72.32 |
| Support Level | $29.31 | $6.84 |
| Resistance Level | $30.54 | N/A |
| Average True Range (ATR) | 1.44 | 0.20 |
| MACD | 0.10 | 0.08 |
| Stochastic Oscillator | 68.18 | 94.13 |
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.
Chatham Lodging Trust is a U.S.-based real estate investment trust that invests in upscale extended-stay hotels. The firm operates across various states in the U.S., including California, New York, Texas, Florida, Minnesota, Massachusetts, and Pennsylvania among others. Substantially all of the company's assets are held and operated by its Operating Partnership, Chatham Lodging, LP. Chatham Lodging LP and its subsidiaries lease the overall company's hotels. The firm operates through a single segment because of the similar economic characteristics of its hotels. Chatham's revenue streams include Room, Food and beverage, and Other. Room comprises the majority of total revenue. Chatham's hotels operate under brands which include, Hilton, Marriott, and Hyatt.